{"id":8534,"date":"2018-03-15T14:23:10","date_gmt":"2018-03-15T13:23:10","guid":{"rendered":"https:\/\/www.satt.fr\/skindermic\/"},"modified":"2018-03-15T14:23:10","modified_gmt":"2018-03-15T13:23:10","slug":"skindermic","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/skindermic\/","title":{"rendered":"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie"},"content":{"rendered":"<p><strong>La SATT IDF Innov et la start-up SkinDermic ont sign\u00e9 en f\u00e9vrier 2018 une licence exclusive. Cette licence concerne t<\/strong><strong>rois demandes de brevets d\u00e9pos\u00e9es dans le cadre de projets ayant fait l\u2019objet de programmes de maturation, pour lesquels IDF Innov a investi 230 K\u20ac. Ainsi, les technologies d\u00e9velopp\u00e9es par SkinDermic vont pouvoir \u00eatre valoris\u00e9es dans le monde industriel de la pharmacie et de la cosm\u00e9tologie. <\/strong><\/p>\n<p>Le Pr. Nicolas Dupin, le Dr. Philippe Grange de l\u2019Institut Cochin (Universit\u00e9 Paris Descartes, Inserm) et les Prs. Vincent Calvez et Anne-Genevi\u00e8ve Marcelin de l\u2019institut Pierre Louis (Sorbonne Universit\u00e9, Inserm), ont fond\u00e9 la start-up SkinDermic dans le but d\u2019exploiter plusieurs technologies accompagn\u00e9es et valoris\u00e9es par la SATT IDF Innov, dans le domaine de la dermatologie :<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Le traitement de l\u2019acn\u00e9 inflammatoire<\/strong><\/p>\n<p>L\u2019acn\u00e9 est une maladie commune qui affecte pr\u00e8s de 85% des adolescents et jeunes adultes des pays industrialis\u00e9s dont 20% pr\u00e9sentent des cas mod\u00e9r\u00e9s \u00e0 s\u00e9v\u00e8res. Elle r\u00e9sulte d\u2019un d\u00e9r\u00e8glement des glandes s\u00e9bac\u00e9es entrainant une surproduction de s\u00e9bum et l\u2019apparition de boutons. Il est aujourd\u2019hui reconnu que l\u2019acn\u00e9 participe fortement aux syndromes de d\u00e9tresse psychologique, d\u00e9pression et accroissement du risque de suicide.<\/p>\n<p>Les traitements actuels sont responsables de nombreux effets secondaires tels qu\u2019une s\u00e9cheresse de la peau, irritations, rougeurs, sensations de br\u00fblures, etc. De plus, ces traitements restent inefficaces car ils ne r\u00e9duisent que de 50% les l\u00e9sions acn\u00e9iques et n\u2019emp\u00eachent pas leur retour. Le besoin m\u00e9dical insatisfait est donc important \u00e0 ce jour.<\/p>\n<p>Les chercheurs acad\u00e9miques ont mis au point un nouveau traitement innovant de l\u2019acn\u00e9 inflammatoire bas\u00e9 sur des petites mol\u00e9cules et peptides. L\u2019\u00e9quipe a d\u2019ores et d\u00e9j\u00e0 d\u00e9montr\u00e9 une forte efficacit\u00e9 des produits \u00e0 r\u00e9duire l\u2019inflammation locale responsable de l\u2019apparition et du d\u00e9veloppement des l\u00e9sions.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>La maladie de Kaposi<\/strong><\/p>\n<p>La maladie de Kaposi est une forme de cancer qui d\u00e9veloppe des l\u00e9sions de la peau, des tissus lympho\u00efdes, des membranes des muqueuses etc, caus\u00e9 par l\u2019herp\u00e8s-virus humain HHV8. Cette maladie affecte notamment les patients infect\u00e9s par le VIH, mais aussi les sujets \u00e2g\u00e9s. Elle est class\u00e9e maladie orpheline. Les chercheurs ont identifi\u00e9 des petites mol\u00e9cules capables de fortement bloquer le d\u00e9veloppement tumoral. Les premiers r\u00e9sultats sont prometteurs et offrent l\u2019espoir d\u2019une nouvelle strat\u00e9gie th\u00e9rapeutique pour lutter contre cette maladie.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.idfinnov.com\/signature-dune-licence-dermatologie\/\">Le communiqu\u00e9 de presse en pdf<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La SATT IDF Innov et la start-up SkinDermic ont sign\u00e9 en f\u00e9vrier 2018 une licence exclusive. Cette licence concerne trois demandes de brevets d\u00e9pos\u00e9es dans le cadre de projets ayant fait l\u2019objet de programmes de maturation, pour lesquels IDF Innov a investi 230 K\u20ac. Ainsi, les technologies d\u00e9velopp\u00e9es par SkinDermic vont pouvoir \u00eatre valoris\u00e9es dans [&hellip;]<\/p>\n","protected":false},"author":22,"featured_media":8519,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[568],"tags":[],"class_list":["post-8534","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-successstories-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/skindermic\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Estelle VIDAL\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/\"},\"author\":{\"name\":\"Estelle VIDAL\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/f31631111412086f92f3dd2a2e132823\"},\"headline\":\"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie\",\"datePublished\":\"2018-03-15T13:23:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/\"},\"wordCount\":458,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/SkinDermic.jpg\",\"articleSection\":[\"Success Stories\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/\",\"name\":\"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/SkinDermic.jpg\",\"datePublished\":\"2018-03-15T13:23:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/f31631111412086f92f3dd2a2e132823\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/SkinDermic.jpg\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/03\\\/SkinDermic.jpg\",\"width\":3200,\"height\":1785,\"caption\":\"Beautiful young woman looking at herself in the mirror\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/skindermic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/f31631111412086f92f3dd2a2e132823\",\"name\":\"Estelle VIDAL\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/estelle\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/skindermic\/","twitter_misc":{"Written by":"Estelle VIDAL","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/skindermic\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/skindermic\/"},"author":{"name":"Estelle VIDAL","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/f31631111412086f92f3dd2a2e132823"},"headline":"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie","datePublished":"2018-03-15T13:23:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/skindermic\/"},"wordCount":458,"image":{"@id":"https:\/\/www.satt.fr\/en\/skindermic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/03\/SkinDermic.jpg","articleSection":["Success Stories"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/skindermic\/","url":"https:\/\/www.satt.fr\/en\/skindermic\/","name":"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/skindermic\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/skindermic\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/03\/SkinDermic.jpg","datePublished":"2018-03-15T13:23:10+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/f31631111412086f92f3dd2a2e132823"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/skindermic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/skindermic\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/skindermic\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/03\/SkinDermic.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/03\/SkinDermic.jpg","width":3200,"height":1785,"caption":"Beautiful young woman looking at herself in the mirror"},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/skindermic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"La SATT IDF Innov et la start-up SkinDermic signent une licence dans le domaine de la dermatologie"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/f31631111412086f92f3dd2a2e132823","name":"Estelle VIDAL","url":"https:\/\/www.satt.fr\/en\/author\/estelle\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/8534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=8534"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/8534\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/8519"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=8534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=8534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=8534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}